We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
-23.28%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$275M
AUM Growth
-$206M
(-43%)
Cap. Flow
-$93.2M
Cap. Flow
% of AUM
-33.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$89M |
| 2 |
ELGX
Endologix Inc
ELGX
|
+$4.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88.48% |
Similar funds
TSM
LI
LIA
IGM
WWM
MWM
LRIC
CIM
Essex Woodlands Management's Q3 2014 Portfolio in Review
As of Q3 2014, Essex Woodlands Management held 11 positions worth $275M, down 43% from $481M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Essex Woodlands Management withdrew a net $93.2M in Q3 2014, closing 1 position and reducing 1 holding. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 88% a quarter earlier.
- Essex Woodlands Management's biggest Q3 2014 reduction was Endologix Inc, cutting an estimated $4.18M.
- Essex Woodlands Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014, selling an estimated $89M.
- Essex Woodlands Management's ten largest holdings make up 100% of its $275M portfolio in Q3 2014.
- Essex Woodlands Management opened 0 new positions and closed 1 in Q3 2014.
- Essex Woodlands Management's portfolio value fell 43% quarter-over-quarter to $275M.
Based on Essex Woodlands Management's 13F filing for Q3 2014, filed 14 Nov 2014.